|
End-of-day quote
Korea S.E.
2026-10-02
|
5-day change | 1st Jan Change | ||
| 993.00 KRW | +1.22% |
|
-0.60% | -40.22% |
Company Valuation: Xcell Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 44,384 | 28,726 |
| Change | - | -35.28% |
| Enterprise Value (EV) 1 | 41,283 | 27,307 |
| Change | - | -33.86% |
| P/E | -4.26x | -1.77x |
| PBR | 4.87x | 4.02x |
| PEG | 0.47x | 1.06x |
| Capitalization / Revenue | 22.9x | 14.7x |
| EV / Revenue | 21.3x | 14x |
| EV / EBITDA | -5.38x | -2.99x |
| EV / EBIT | -4.42x | -2.52x |
| EV / FCF | -8.13x | -4.03x |
| FCF Yield | -12.3% | -24.8% |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -954 | -938 |
| Distribution rate | - | - |
| Net sales 1 | 1,934 | 1,949 |
| EBITDA 1 | -7,677 | -9,148 |
| EBIT 1 | -9,330 | -10,852 |
| Net income 1 | -9,543 | -10,927 |
| Net Debt 1 | -3,100 | -1,419 |
| Reference price 2 | 4,065.00 | 1,661.00 |
| Nbr of stocks (in thousands) | 10,918 | 17,294 |
| Announcement Date | 3/20/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 12.75M | ||
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | ||
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | ||
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | ||
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | ||
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | ||
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | ||
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | ||
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | ||
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | ||
| Average | 26.61x | 6.52x | 17.28x | 2.29% | 369.72B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A373110 Stock
- Valuation Xcell Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















